Saturday, 13. March 2010

Life sciences

Policy support

International co-operation

Reporting module


NHR DEVTOX - A Prospective Analysis of the Mechanisms of Nuclear Hormone Receptors and their Potential as Tools for the Assessment of Developmental Toxicity (Life sciences, genomics and biotechnology for health) (2005-01-01 - 2005-11-30) (»add to infobox)



ACRONYM:NHR DEVTOX
BUDGET:144.107 €
FUNDING:144.107 €
INSTRUMENT:Specific Support Action
PROGRAMME:Life sciences, genomics and biotechnology for health
In view of developing an innovative non-animal test method for chemicals, medicines, biological and bio-materials, the proposed project has the final goal of producing a prospective analysis of the mechanisms of nuclear hormone receptors and their potential as tools for the assessment of developmental toxicity. The prospective analysis will either define a practical research programme for future RDT activities in this field, or conclude that the area is not sufficiently mature at present time. The specific objectives of the project are the following: - To investigate the role of nuclear hormone receptors in developmental and reproductive biology and to review the state of the science in this field; - To define a practical research programme with the aim of enhancing knowledge on the mechanisms of developmental toxicity and the role of nuclear receptors in the process; - To develop a plan aimed at applying such understanding to the future assessment of the relevance of in vitro systems as predictive models for developmental toxicity. The project, proposed as an SSA, consists of two workshops where the best European research resources in the area of molecular biology, genomics and developmental toxicology will be pooled together with the aim of investigating the role of nuclear hormone receptors in developmental and reproductive biology.

Keywords:
Animal alternatives. Genomics. Molecular bioloav. Developmental toxicity.

COORDINATOR (1/1) 


Michael George PENMAN (Contact / EXXONMOBIL PETROLEUM AND CHEMICAL (BE211 - Arr. Antwerpen) (BE - Belgium))

PARTICIPANTS (8/8) 


Clifford Roy ELCOMBE (Contact / CXR BIOSCIENCES LTD (UKM21 - Angus and Dundee City) (UK - Great Britain))

Aleksi SEDO (Contact / UNIVERZITA KARLOVA V PRAZE (CZ010 - Hlavni mesto Praha) (CZ - Czech Republic))

Margarita HADZOPOULOU-CLADARAS (Contact / ARISTOTELIO PANEPISTIMIO THESSALONIKIS (GR122 - Thessaloniki) (GR - Greece))

Jaroslaw DASTYCH (Contact / POLISH ACADEMY OF MEDICINE (PL113 - Miasto Lodz) (PL - Poland))

Jiri STULIK (Contact / UNIVERZITA OBRANY FAKULTA VOJENSKEHO ZDRAVOTNICTVI, HRADEC KRALOVE (CZ052 - Kralovehradecky kraj) (CZ - Czech Republic))

Monika PUZIANOWSKA-KUZNICKA (Contact / POLISH ACADEMY OF SCIENCES (PL127 - Miasto Warszawa) (PL - Poland))

Francis Mario CARPANINI (Contact / FRANCIS CARPANINI (UKJ11 - Berkshire) (UK - Great Britain))

Maciej STEPNIK (Contact / INSTYTUT MEDYCYNY PRACY NOFER (PL113 - Miasto Lodz) (PL - Poland))

RELATED THEMATIC AREAS (1/1) 

Development of new in vitro tests to replace animal experimentation




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



LAST PAGES (3/22) show all
»
Thematic area: Molecular-oriented detection and treatment of minimal disease
»
Person: Per LENNER
»
Project: Innovative Chemokine-based Therapeutic Strategies for Autoimmunity and Chronic Inflammation


INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


STOCKHOLM-UPPSALA LIFE SCIENCE
Powered by CONVERIS 2.0